Hyaluromimethic Technology

Hyaluromimethic Technology is BMG’s patented state of art technology of modifying Sodium Hyaluronate on its hydroxylic bonds. This novel technology with its outstanding features is suitable for development of topical and injectable products in dermatology, ophthalmology, periodontology and more.

Menu